Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SUNOVION PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS USA, INC. et al
Case Number:
2:09-cv-01302
Court:
Nature of Suit:
Judge:
Firms
- Carella Byrne
- Eckert Seamans
- Flaster Greenberg
- Fox Rothschild
- Kaplan Breyer
- Lite DePalma
- Midlige Richter
- Patunas Law
- Paul Hastings
- Saiber LLC
- Saul Ewing
- Sills Cummis
- Snyder Sarno
- Windels Marx
- Winston & Strawn
Companies
- Dr. Reddy's Laboratories Ltd.
- Glenmark Pharmaceuticals Ltd.
- Lupin Ltd.
- Mylan NV
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Wockhardt Ltd.
- Wockhardt USA LLC
Sectors & Industries:
-
April 05, 2013
Sun Pharma Agrees Not To Sell Generics Of Sleep Aid Lunesta
A New Jersey federal judge approved a final settlement Thursday in Sunovion Pharmaceuticals Inc.'s patent infringement suit against Sun Pharma Global Inc. over its sleep aid drug Lunesta, a deal that bars Sun Pharma from making or selling a generic version of Lunesta before April 2014.
-
April 02, 2013
Mylan Settles With Sunovion Over Lunesta Generic Plans
Generic drugmaker Mylan Inc. on Tuesday agreed to a settlement with Sunovion Pharmaceuticals Inc., ending claims that one of its units' planned generic version of sleep aid Lunesta infringed several Sunovion patents, according to an agreement filed in New Jersey federal court.
-
January 22, 2013
Dr. Reddy's Generic Found Not To Infringe Lunesta Patent
A New Jersey federal judge on Thursday found that Dr. Reddy's Laboratories Ltd. didn't infringe a patent belonging to Sunovion Pharmaceuticals Inc. for its blockbuster drug Lunesta, finding that Dr. Reddy's proposed generic version of the sleep aid is chemically different.